Ticker brief
QNTM QUANTUM BIOPHARMA-B SUB VOT
Consumer, Non-cyclical · Pharmaceuticals
last close
$3.08
1 day
-1.6%
14 days
-18.9%
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
-2.8σ
Sentiment — last 14 days
daily mean sentiment, 2026-08-14 → 2026-08-24 · now -0.62 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @SittingBear0921 | C | +0.22 | 2 | -0.65 |
| @TarekMM100 | C | +0.27 | 1 | +0.00 |
| @AGORACOM | C | +1.24 | 1 | +0.50 |
| @Greatstockpix | C | -0.89 | 1 | +0.50 |
| @ZacMannes | C | +2.45 | 1 | -0.55 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-24 | @SittingBear0921 | -0.70 | Discloses having shorted the listed positions during the day. | -4.9% | tweet ↗ |
| 2026-08-24 | @ZacMannes | -0.55 | Author says he has not been bullish and cites the stock's failure to hold reliable support. | -4.9% | tweet ↗ |
| 2026-08-23 | @SittingBear0921 | -0.60 | Insults holders or promoters of the four named securities, expressing strongly negative sentiment. | -10.5% | tweet ↗ |
| 2026-08-17 | @Greatstockpix | +0.50 | FDA approved Lucid-MS to proceed to a pivotal Phase 2 clinical trial. | -16.3% | tweet ↗ |
| 2026-08-16 | @AGORACOM | +0.50 | Roundup reports QNTM FDA clearance plus positive revenue, contract, acquisition and drilling updates. | -18.9% | tweet ↗ |
| 2026-08-14 | @TarekMM100 | +0.00 | Ticker and unseen media provide insufficient standalone stance. | -18.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.